New App Calculates Women’s Risk for Advanced Breast Cancer
A new digital tool helps to calculate breast cancer risk for those who may develop advanced cancer that goes undiagnosed despite regular screenings.
University of California San Francisco
Give to UCSF
Paid Sick Leave Means More People Get Screened for Cancer
Sick leave coverage expansion were associated with higher rates of mammography screening and colorectal screening, potentially leading to better health outcomes.
“Smarter” Breast Cancer Screening Measures Risk Down to Your DNA
The WISDOM 2.0 study aims to transform breast cancer screening by using a personalized approach and will expand to women as young as 30.
Breast Cancer Risk Calculator Can Assess Risk of Advanced Cancer
A new digital tool helps calculate breast cancer risk for those who may develop advanced cancer that goes undiagnosed despite regular screenings.
International Conference Features UCSF Breast Cancer Experts
UCSF breast cancer experts will present new research and clinical findings at the annual San Antonio Breast Cancer Symposium, the largest and most prestigious breast cancer conference.
UCSF Hosts First Lady Jill Biden to Discuss Breast Cancer Research
First Lady Jill Biden, Ed.D, met with top UCSF cancer leaders during a visit Friday, October 7th, to hear about UCSF’s breast cancer research and progress on the National Cancer Moonshot.
Abortion Ban May Increase Risk of Death for Pregnant Women with Cancer
The repercussions of overturning Roe v. Wade – and the failure of the Supreme Court to provide any guidance on exceptions related to the life and health of the mother – are potentially catastrophic for women who face a life-threating diagnosis of pregnancy associated cancers (PAC).
Hearing Loss and Tinnitus Are Common In Cancer Survivors
A new UCSF study reports for the first time that significant hearing issues often occur among adult survivors of the most common forms of cancer.
3-D Mammography Technique Benefits Some Women, Not All
For many women, breast cancer screening with a three-dimensional imaging technique called digital breast tomosynthesis (DBT) may not offer advantages over digital mammography, but for some it may reduce the chance of an advanced cancer diagnosis, according to a new JAMA study.
New Biomarker Classifications May Improve Treatment for High-Risk Breast Cancer Patients
UCSF research scientists and statisticians have developed improved biomarker classifications as part of their research results in the I-SPY 2 trial for high-risk breast cancer patients. The new cancer response subtypes reflect responsiveness to drug treatments and are intended to help clinicians be more precise in how they target therapies.
UCSF Cancer Specialists to Present Clinical Findings at Major Conference
The latest advances in cancer care and research will be showcased at the annual American Society of Clinical Oncology (ASCO) Annual Meeting, the world’s largest clinical cancer meeting.
